{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T09:35:46Z","timestamp":1789896946680,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T00:00:00Z","timestamp":1164931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,6]],"date-time":"2016-07-06T00:00:00Z","timestamp":1467763200000},"content-version":"vor","delay-in-days":3505,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1016\/j.jtcvs.2006.07.025","type":"journal-article","created":{"date-parts":[[2006,11,1]],"date-time":"2006-11-01T01:25:28Z","timestamp":1162344328000},"page":"1356-1362.e2","source":"Crossref","is-referenced-by-count":36,"title":["Gossypol, a phytochemical with BH3-mimetic property, sensitizes cultured thoracic cancer cells to Apo2 ligand\/tumor necrosis factor\u2013related apoptosis-inducing ligand"],"prefix":"10.25013","volume":"132","author":[{"given":"Wen-Shuz","family":"Yeow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Baras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duc M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shailen S.","family":"Sehgal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Schrump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dao M.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtcvs.2006.07.025_bib1","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1172\/JCI6926","article-title":"Safety and antitumor activity of recombinant soluble Apo2 ligand","volume":"104","author":"Ashkenazi","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/sj.bjc.6602487","article-title":"HGS-ETR1, a fully human TRAIL-receptor 1 monoclonal antibody, induces cell death in multiple tumour types in vitro and in vivo","volume":"92","author":"Pukac","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib3","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/86397","article-title":"Differential hepatocyte toxicity of recombinant Apo2L\/TRAIL versions","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0022-3565(24)29298-3","article-title":"Preclinical studies to predict the disposition of Apo2L\/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety","volume":"299","author":"Kelley","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib5","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.cdd.4401187","article-title":"Apo2L\/TRAIL and its death and decoy receptors","volume":"10","author":"LeBlanc","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib6","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/sj.cgt.7700792","article-title":"Mechanisms of resistance to TRAIL-induced apoptosis in cancer","volume":"12","author":"Zhang","year":"2005","journal-title":"Cancer Gene Ther"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/00130404-200607000-00004","article-title":"The essential role of the mitochondria-dependent death signaling cascade in chemotherapy-induced potentiation of Apo2L\/TRAIL cytotoxicity in cultured thoracic cancer cells: amplified caspase 8 is indispensable for combination-mediated massive cell death","volume":"12","author":"Nguyen","year":"2006","journal-title":"Cancer J"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib8","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1593\/neo.05823","article-title":"Valproic acid, an anti-epileptic drug with histone deacetylase inhibitory activity, potentiates the cytotoxic effect of Apo2L\/TRAIL on cultured thoracic cancer cells via mitochondria-dependent caspase activation","volume":"8","author":"Ziauddin","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib9","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1038\/sj.onc.1207704","article-title":"Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP","volume":"23","author":"Muhlethaler-Mottet","year":"2004","journal-title":"Oncogene"},{"issue":"Suppl 2","key":"10.1016\/j.jtcvs.2006.07.025_bib10","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1038\/sj.cdd.4401535","article-title":"Histone deacetylase inhibitors potentiate TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in lymphoid malignancies","volume":"11","author":"Inoue","year":"2004","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.physiol.60.1.619","article-title":"The mitochondrial death\/life regulator in apoptosis and necrosis","volume":"60","author":"Kroemer","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4161\/cbt.4.4.1616","article-title":"Enhancing TRAIL-induced apoptosis by BclXL siRNA","volume":"4","author":"Zhu","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.molcel.2005.02.003","article-title":"BH3 comains of BH3-only proteins differentially regulate Bax-mediated mitochondria membrane permeabilization both directly and indirectly","volume":"17","author":"Kuwana","year":"2005","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1182\/blood-2004-07-2761","article-title":"Apoptosis-based therapies for hematologic malignancies","volume":"106","author":"Reed","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-4598-4-23","article-title":"(-)-Gossypol acts directly on the mitochondria to overcome Bcl-2- and Bcl-XL-mediated apoptosis resistance","volume":"4","author":"Oliver","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1023\/A:1010686204736","article-title":"Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I\/II clinical trial","volume":"66","author":"Van Poznak","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib17","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1021\/jm030190z","article-title":"Discovery, characterization and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte\/leukemia-2 proteins","volume":"46","author":"Kitada","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.drup.2004.03.002","article-title":"Enhancement of therapeutic potential of TRAIL by cancer chemotherapy and irradiation: mechanisms and clinical implications","volume":"7","author":"Shankar","year":"2004","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib19","doi-asserted-by":"crossref","first-page":"7611","DOI":"10.1038\/sj.onc.1207970","article-title":"Cooperation of betulinic acid and TRAIL to induce apoptosis in tumor cells","volume":"23","author":"Fulda","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-4598-4-13","article-title":"Preclinical studies of a nonpeptidic small-molecule inhibitor of Bcl-2 and Bcl-XL [(-)-gossypol] against diffuse large cell lymphoma","volume":"4","author":"Mohammad","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib22","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1158\/0008-5472.CAN-03-3648","article-title":"Bcl-2 inhibitors sensitize tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by uncoupling of mitochondria respiration in human leukemic CEM cells","volume":"64","author":"Hao","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtcvs.2006.07.025_bib23","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1007\/s10495-005-2490-y","article-title":"Sensitization of prostate carcinoma cells to Apo2L\/TRAIL by a Bcl-2 family protein inhibitor","volume":"10","author":"Ray","year":"2005","journal-title":"Apoptosis"}],"container-title":["The Journal of Thoracic and Cardiovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522306013559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022522306013559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T19:12:12Z","timestamp":1736622732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022522306013559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["S0022522306013559"],"URL":"https:\/\/doi.org\/10.1016\/j.jtcvs.2006.07.025","relation":{},"ISSN":["0022-5223"],"issn-type":[{"value":"0022-5223","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}